Welcome to our dedicated page for Eltek SEC filings (Ticker: ELTK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Eltek Ltd. filings document foreign private issuer reporting for a printed circuit board manufacturer whose annual reports are filed on Form 20-F and interim company updates are furnished on Form 6-K. The disclosures cover audited consolidated financial statements, quarterly and annual results, order activity, earnings-call notices and operating outlook information for its PCB business.
Eltek’s filing record also includes references to registration statements on Form F-3 and Form S-8, linking certain Form 6-K disclosures to securities registration and equity plan records. Company-specific disclosures describe HDI, multilayer and flex-rigid PCB production, defense, aerospace and medical customers, Israel-based operations, a North American subsidiary, and compliance certifications relevant to its manufacturing markets.
Eltek Ltd director Mordechai Marmorstein has reported existing employee stock option holdings in a Form 3 filing. He holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter. The earlier grant was made on September 6, 2021, and the later grant on October 10, 2023.
ELTEK LTD executive Yitzhak Zemach, Vice President Operations, has reported his existing equity holdings on a Form 3. The filing lists five grants of employee stock options over a total of 42,500 underlying ordinary shares, with exercise prices ranging from $4.9400 to $15.8300 and expirations between 2031 and 2036. Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and an additional 6.25% at the end of each following quarter.
ELTEK LTD director Ilana Lurie reported existing equity awards in the form of employee stock options. She holds options over 10,000 ordinary shares at an exercise price of $5.8900 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.6700 per share expiring on October 6, 2033.
Each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant dates in September 2021 and October 2023, and an additional 6.25% becoming exercisable at the end of each subsequent quarter.
Eltek Ltd VP Sales and Marketing Tomer Segev filed an initial Form 3 reporting holdings of employee stock options. He holds options linked to 20,000 ordinary shares with a $10.51 exercise price expiring on November 18, 2034, granted on November 18, 2024, and options linked to 6,000 ordinary shares with a $8.82 exercise price expiring on March 8, 2036, granted on March 8, 2026. Both grants vest over four years, with 25% vesting after one year and 6.25% at the end of each following quarter.
Eltek Ltd director Dovev Gad has reported existing equity awards through a Form 3 filing. He holds employee stock options over 20,000 ordinary shares with an exercise price of $5.89 per share, expiring on September 6, 2031.
He also holds options over 10,000 ordinary shares with an exercise price of $8.67 per share, expiring on October 6, 2033. Footnotes state each grant vests over four years, with 25% vesting after one year from the grant date and 6.25% at the end of each following quarter.
Eltek Ltd Chief Executive Officer Eli Yaffe filed an initial Form 3 that lists his existing equity position in the company. He holds employee stock options over 8,480 ordinary shares at an exercise price of $3.59 expiring on November 14, 2028, 21,308 shares at $4.17 expiring on December 29, 2030, 25,000 shares at $8.70 expiring on August 3, 2033, and 20,000 shares at $15.83 expiring on March 10, 2034.
The option agreements provide four-year vesting, with 25% exercisable on the first anniversary of the grant date and an additional 6.25% at the end of each subsequent quarter. Yaffe also directly holds 7,250 ordinary shares, giving him a mix of current ownership and long-dated equity incentives.
Eltek Ltd. director David Rubner filed an initial ownership report showing stock option holdings. He holds employee stock options over 10,000 ordinary shares at an exercise price of $5.89 per share expiring on September 6, 2031, and options over another 10,000 ordinary shares at $8.67 per share expiring on October 6, 2033. Footnotes state each option grant vests over four years, with 25% becoming exercisable on the first anniversary of the grant date and 6.25% at the end of each following quarter, for grants dated September 6, 2021 and October 10, 2023.
Eltek Ltd. reported higher 2025 revenue but sharply lower profit as it upgraded and relocated manufacturing to support new plating lines. Full-year revenue rose to $51.8M from $46.5M, yet gross margin fell to 15% and operating income dropped to $2.3M from $4.4M.
Net income declined to $0.8M or $0.12 per diluted share, compared with $4.2M or $0.63 in 2024, hurt by operational disruption, workforce challenges and a weaker U.S. dollar versus the Israeli shekel that added about $2.2M to shekel-based expenses.
In the fourth quarter, revenue increased to $13.2M, but Eltek posted a net loss of $0.3M as gross margin compressed. EBITDA for 2025 was $4.5M (9% of revenue) versus $5.9M (13%) a year earlier. Management frames the heavy capital spending and modernization as positioning the company for long-term growth in defense and medical PCB markets.
Eltek Ltd. filed a Form 6-K to share details about its upcoming earnings release and conference call. The company will publish financial results for the fourth quarter and year ended December 31, 2025 before the market opens on March 9, 2026.
On March 9, 2026 at 9:30 a.m. Eastern Time, Eltek will host a conference call featuring CEO Eli Yaffe and CFO Ron Freund to discuss these results. The release and a replay of the call will be available through the Investor Info section of Eltek’s website.
Eltek Ltd. reported new purchase orders totaling $12.2 million from an American defense customer. The printed circuit board products covered by these orders are scheduled for delivery throughout 2026 and 2027 and will be used in a defense project.
The company highlighted that this win supports its strategic goal of expanding its presence in the U.S. market with high value-added products. Eltek positions itself as a global provider of advanced, complex PCBs serving defense, aerospace and medical customers across multiple regions.